Alps Advisors Inc Alector, Inc. Transaction History

Alps Advisors Inc

$15.7 Billion
Q4 2024

A detailed history of Alps Advisors Inc transactions in Alector, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 79,115 shares of ALEC stock, worth $72,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,115

Previous 77,232 2.44%

Holding current value

$72,785

Previous $360,000 58.61%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$1.72 - $6.06 $3,238 - $11,410	1,883 Added 2.44%	79,115 $149,000
Q3 2024 Nov 12, 2024	BUY	$4.34 - $6.58 $8,918 - $13,521	2,055 Added 2.73%	77,232 $360,000
Q2 2024 Aug 13, 2024	BUY	$4.19 - $6.23 $32,036 - $47,634	7,646 Added 11.32%	75,177 $341,000
Q1 2024 May 14, 2024	BUY	$5.69 - $8.08 $61,116 - $86,787	10,741 Added 18.91%	67,531 $406,000
Q4 2023 Feb 14, 2024	SELL	$3.77 - $8.39 $19,008 - $42,302	-5,042 Reduced 8.15%	56,790 $453,000
Q3 2023 Nov 14, 2023	BUY	$5.2 - $8.77 $2,922 - $4,928	562 Added 0.92%	61,832 $400,000
Q2 2023 Aug 14, 2023	BUY	$5.86 - $7.93 $38,476 - $52,068	6,566 Added 12.0%	61,270 $368,000
Q1 2023 May 10, 2023	SELL	$5.85 - $9.84 $7,926 - $13,333	-1,355 Reduced 2.42%	54,704 $338,000
Q4 2022 Feb 14, 2023	BUY	$6.88 - $9.55 $75,707 - $105,088	11,004 Added 24.42%	56,059 $517,000
Q3 2022 Nov 14, 2022	SELL	$8.19 - $13.2 $31,007 - $49,975	-3,786 Reduced 7.75%	45,055 $426,000
Q2 2022 Aug 11, 2022	SELL	$7.65 - $14.24 $270,993 - $504,437	-35,424 Reduced 42.04%	48,841 $496,000
Q1 2022 May 16, 2022	SELL	$13.02 - $20.78 $127,478 - $203,456	-9,791 Reduced 10.41%	84,265 $1.2 Million
Q4 2021 Feb 09, 2022	SELL	$19.35 - $25.54 $98,123 - $129,513	-5,071 Reduced 5.12%	94,056 $1.94 Million
Q3 2021 Nov 15, 2021	SELL	$21.65 - $39.49 $111,107 - $202,662	-5,132 Reduced 4.92%	99,127 $2.26 Million
Q2 2021 Aug 11, 2021	SELL	$15.5 - $22.48 $606,205 - $879,192	-39,110 Reduced 27.28%	104,259 $2.17 Million
Q1 2021 May 07, 2021	BUY	$14.84 - $22.23 $1,498 - $2,245	101 Added 0.07%	143,369 $2.89 Million
Q4 2020 Feb 03, 2021	BUY	$9.4 - $16.7 $396,548 - $704,506	42,186 Added 41.73%	143,268 $2.17 Million
Q3 2020 Nov 04, 2020	SELL	$10.54 - $24.96 $70,870 - $167,831	-6,724 Reduced 6.24%	101,082 $1.07 Million
Q2 2020 Aug 05, 2020	SELL	$21.87 - $33.11 $706,554 - $1.07 Million	-32,307 Reduced 23.06%	107,806 $2.64 Million
Q1 2020 May 06, 2020	BUY	$16.25 - $35.28 $19,418 - $42,159	1,195 Added 0.86%	140,113 $3.38 Million
Q4 2019 Feb 07, 2020	BUY	$14.17 - $20.3 $1.97 Million - $2.82 Million	138,918 New	138,918 $2.39 Million

Others Institutions Holding ALEC

# of Institutions

159

Shares Held

55M

Call Options Held

39.7K

Put Options Held

51K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $76M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Alector, Inc. Transaction History